GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
56.66
+0.67 (1.20%)
Apr 2, 2026, 10:22 AM EDT - Market open

GSK Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
112,18998,40569,00576,19475,70895,031
Market Cap Growth
36.13%42.61%-9.44%0.64%-20.33%19.87%
Enterprise Value
130,763117,08884,70291,83190,961130,352
Last Close Price
56.6649.0433.8237.0335.1244.10
PE Ratio
14.5813.1421.6612.133.9615.07
PS Ratio
2.552.241.751.972.132.85
PB Ratio
5.224.474.024.485.904.67
P/TBV Ratio
7.116.165.125.706.775.94
P/FCF Ratio
13.2911.4510.6710.9710.0010.04
P/OCF Ratio
10.779.458.398.848.458.84
EV/Sales Ratio
2.972.672.152.382.563.90
EV/EBITDA Ratio
8.578.5010.277.988.7614.88
EV/EBIT Ratio
10.2810.9816.7910.7011.6922.13
EV/FCF Ratio
15.4913.6213.0913.2312.0113.77
Debt / Equity Ratio
1.111.111.301.412.081.13
Debt / EBITDA Ratio
1.731.732.591.992.453.73
Debt / FCF Ratio
2.772.773.303.303.353.45
Net Debt / Equity Ratio
0.870.870.960.961.241.32
Net Debt / EBITDA Ratio
1.401.401.991.421.533.06
Net Debt / FCF Ratio
2.242.242.542.352.092.83
Asset Turnover
0.540.540.530.510.420.31
Inventory Turnover
1.561.561.621.611.751.39
Quick Ratio
0.520.520.520.610.670.54
Current Ratio
0.820.820.780.880.910.79
Return on Equity (ROE)
43.31%43.31%22.80%46.38%99.38%24.18%
Return on Assets (ROA)
11.18%11.18%5.76%9.91%8.08%5.34%
Return on Invested Capital (ROIC)
16.57%16.57%8.86%16.17%12.19%7.44%
Return on Capital Employed (ROCE)
20.47%20.47%10.62%17.92%13.87%7.66%
Earnings Yield
6.86%7.61%4.62%8.24%25.23%6.63%
FCF Yield
7.52%8.74%9.37%9.11%10.00%9.96%
Dividend Yield
3.10%3.47%4.45%3.81%5.93%6.13%
Payout Ratio
93.86%44.86%94.91%45.60%23.18%91.20%
Buyback Yield / Dilution
0.60%0.60%-0.75%-0.66%-0.79%-0.55%
Total Shareholder Return
3.70%4.07%3.69%3.15%5.14%5.58%
Updated Feb 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q